Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FP-R01-MG-F2 PET/CT in IPF, PSC, and COVID-19
NCT03183570Phase 1Completed
- Sponsor
- Stanford University
- Start
- Nov 2017
- Primary completion
- Apr 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of fluorine F 18 FP-R01-MG-F2 (3 arms), sponsored by Stanford University. Primary endpoint: Standardized Uptake Value Maximum at 2 hours. Started Nov 2017; status: completed.
02
Drugs
fluorine F 18 FP-R01-MG-F2
Beyond the preview
Go deeper on NCT03183570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183570.